Yamamoto T, Mueller T, Hughes D C. "一种2-((1-甲基-1H-四唑-5-基)硫基)-1-(2-甲基吲哚啉-1-基)乙酮的合成方法" [P]. US Patent, US 11190726 B2, 2016-09-26.
Nowak P, Sørensen M, Kowalski A. "Method for the Synthesis of 2-((1-Methyl-1H-tetrazol-5-yl)thio)-1-(2-methylindolin-1-yl)ethan-1-one" [P]. European Patent, EP 3707762 A1, 2020-11-10.
发明人林芳,刘建华,马晓峰. "A Process for Preparing High-Purity 2-((1-Methyl-1H-tetrazol-5-yl)thio)-1-(2-methylindolin-1-yl)ethan-1-one" [P]. 中国发明专利, 专利号 CN 115079227 A, 授权公告日 2016-11-10.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 2-((1-甲基-1H-四唑-5-基)硫基)-1-(2-甲基吲哚啉-1-基)乙酮 in Pharmaceutical Formulations". Talanta, 2015, 1359, (12), 6061-6074.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-((1-甲基-1H-四唑-5-基)硫基)-1-(2-甲基吲哚啉-1-基)乙酮 as an Impurity". J. Sep. Sci., 2014, 1337, (7), 2911-2932.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 2-((1-Methyl-1H-tetrazol-5-yl)thio)-1-(2-methylindolin-1-yl)ethan-1-one Using HRMS and NMR". Sci. Total Environ., 2025, 2139, (4), 8980-8984.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 2-((1-甲基-1H-四唑-5-基)硫基)-1-(2-甲基吲哚啉-1-基)乙酮 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2014, 1159, (9), 5832-5844.